Updates are available Correction dated 2021-03-17
Click to view Correction: https://doi.org/10.1038/s41571-021-00497-x
-
Authors
Ragoonanan, Dristhi https://orcid.org/0000-0002-8199-9404
Khazal, Sajad J. https://orcid.org/0000-0002-3731-608X
Abdel-Azim, Hisham
McCall, David https://orcid.org/0000-0003-2297-9670
Cuglievan, Branko
Tambaro, Francesco Paolo
Ahmad, Ali Haider
Rowan, Courtney M.
Gutierrez, Cristina
Schadler, Keri
Li, Shulin
Di Nardo, Matteo
Chi, Linda
Gulbis, Alison M.
Shoberu, Basirat
Mireles, Maria E.
McArthur, Jennifer
Kapoor, Neena
Miller, Jeffrey
Fitzgerald, Julie C. https://orcid.org/0000-0001-9936-9569
Tewari, Priti
Petropoulos, Demetrios
Gill, Jonathan B.
Duncan, Christine N.
Lehmann, Leslie E.
Hingorani, Sangeeta
Angelo, Joseph R.
Swinford, Rita D.
Steiner, Marie E.
Hernandez Tejada, Fiorela N.
Martin, Paul L.
Auletta, Jeffery
Choi, Sung Won https://orcid.org/0000-0002-6321-3834
Bajwa, Rajinder https://orcid.org/0000-0003-4498-0322
Dailey Garnes, Natalie https://orcid.org/0000-0002-4016-4929
Kebriaei, Partow
Rezvani, Katayoun
Wierda, William G.
Neelapu, Sattva S. https://orcid.org/0000-0003-1045-4914
Shpall, Elizabeth J.
Corbacioglu, Selim
Mahadeo, Kris M. https://orcid.org/0000-0003-2649-9674
- License Information
-
More Information
Article History
Accepted: 13 January 2021
First Online: 19 February 2021
Change Date: 17 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41571-021-00497-x
Competing interests
: C.G. has served on the advisory board for Janssen and Legend Biotech. A relative of J.B.G. is a consultant to Acceleron and Celgene. K.R. and E.J.S. have a licence agreement with Takeda. E.J.S. has served on the advisory boards of Adaptimmune, Axio, Bayer, Celgene, Magenta, Mesoblast and Novartis. K.M.M. serves as a site investigator for, receives research funding from and has served as a medical consultant for Atara Biotherapeutics, and has received research and medical education funds from and served as a medical consultant for Jazz Pharmaceuticals. All other authors declare no competing interests.
